» Articles » PMID: 38929957

Calcinosis Prevalence in Autoimmune Connective Tissue Diseases-A Retrospective Study

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Jun 27
PMID 38929957
Authors
Affiliations
Soon will be listed here.
Abstract

: Calcinosis cutis is the deposition of insoluble calcium salts, which may cause inflammation, ulceration, pain, and restricted joint mobility. It rarely develops in damaged tissues (dystrophic subtype), most frequently in autoimmune connective tissue diseases (CTDs), but there is very limited data on the prevalence. Also, therapy remains an unsolved issue. In this study, we aimed to collect data on the prevalence of calcinosis in CTD patients to highlight that it is a considerable problem. : A retrospective study was conducted in our department to assess the epidemiology of dystrophic calcinosis in CTDs between January 2003 and January 2024. : A total of 839 CTD patients were identified, of whom 56 had calcinosis (6.67%). The mean age of the calcinosis patients at diagnosis of underlying CTD was 41.16 ± 19.47 years. The mean time interval from the onset of calcinosis was 5.96 ± 8.62 years. Systemic sclerosis was the most common CTD complicated by calcinosis (n = 22). : Our results are comparable to those reported previously in the literature. Although calcinosis is rare in the overall population, it is a present and unsolved problem in CTD patients. Therefore, further studies are needed on the factors involved in the development and progression of calcinosis as well as its treatment.

Citing Articles

Treatment of Calcinosis in Dermatomyositis-Case Report and Review.

Fraczek A, Kuna J, Rybak dObyrn J, Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A J Clin Med. 2024; 13(20).

PMID: 39458184 PMC: 11508430. DOI: 10.3390/jcm13206234.

References
1.
Cruz-Dominguez M, Garcia-Collinot G, Saavedra M, Medina G, Carranza-Muleiro R, Vera-Lastra O . Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol. 2016; 36(1):111-117. DOI: 10.1007/s10067-016-3412-9. View

2.
Penate Y, Guillermo N, Melwani P, Martel R, Hernandez-Machin B, Borrego L . Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin. J Am Acad Dermatol. 2009; 60(6):1076-7. DOI: 10.1016/j.jaad.2008.09.051. View

3.
Asano Y, Sato S . Vasculopathy in scleroderma. Semin Immunopathol. 2015; 37(5):489-500. DOI: 10.1007/s00281-015-0505-5. View

4.
Tiao J, Gaffney R, Fedeles F . A Retrospective Study of Calcinosis Cutis in Patients With Systemic Lupus Erythematosus. J Drugs Dermatol. 2022; 21(10):1137. View

5.
Freire V, Becce F, Feydy A, Guerini H, Campagna R, Allanore Y . MDCT imaging of calcinosis in systemic sclerosis. Clin Radiol. 2012; 68(3):302-9. DOI: 10.1016/j.crad.2012.07.009. View